ATE297945T1 - Glutathionderivate und dazugehörige dosisformen - Google Patents

Glutathionderivate und dazugehörige dosisformen

Info

Publication number: ATE297945T1
Authority: AT; Austria
Prior art keywords: alkyl group; group; dosage forms; alkenyl group; derivative
Prior art date: 1998-04-16

Application number

AT99914763T

Other languages

English (en)

Inventor

Kiyoyuki Sakon

Yoshimitsu Naniwa

Mitsuru Kobayashi

Daishiro Miura

Hiroshi Imai

Atsushi Imaizumi

Original Assignee

Teijin Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-16

Filing date

1999-04-16

Publication date

2005-07-15

1999-04-16 Application filed by Teijin Ltd filed Critical Teijin Ltd

2005-07-15 Application granted granted Critical

2005-07-15 Publication of ATE297945T1 publication Critical patent/ATE297945T1/de

Links

RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical class OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title abstract 4
239000002552 dosage form Substances 0.000 title 1
125000003342 alkenyl group Chemical group 0.000 abstract 4
125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
230000018109 developmental process Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000011132 hemopoiesis Effects 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

AT99914763T 1998-04-16 1999-04-16 Glutathionderivate und dazugehörige dosisformen ATE297945T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP10635998		1998-04-16
PCT/JP1999/002044 WO1999054346A1 (en)	1998-04-16	1999-04-16	Glutathione derivatives and dosage forms thereof

Publications (1)

Publication Number	Publication Date
ATE297945T1 true ATE297945T1 (de)	2005-07-15

Family

ID=14431564

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99914763T ATE297945T1 (de)	1998-04-16	1999-04-16	Glutathionderivate und dazugehörige dosisformen

Country Status (10)

Country	Link
US (2)	US6627732B1 (de)
EP (1)	EP1072608B1 (de)
JP (1)	JP4059627B2 (de)
KR (1)	KR20010042752A (de)
AT (1)	ATE297945T1 (de)
AU (1)	AU766515B2 (de)
CA (1)	CA2328731A1 (de)
DE (1)	DE69925824D1 (de)
TW (1)	TW576838B (de)
WO (1)	WO1999054346A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7029695B2 (en)	2001-07-10	2006-04-18	Telik, Inc.	Therapeutic compositions containing glutathione analogs
US6747009B2 (en) *	2002-09-19	2004-06-08	Universiteit Leiden	Peptidomimetic glutathione analogs
US8198247B2 (en) *	2004-12-21	2012-06-12	Telik, Inc.	Process for and intermediates in the preparation of canfosfamide and its salts
EP1833978B1 (de) *	2005-01-06	2008-10-08	Telik, Inc.	Tripeptid- und tetrapeptid-thioether
US7446096B2 (en) *	2005-12-19	2008-11-04	Industrial Technology Research Institute	Glutathione based delivery system
US8067380B2 (en)	2005-12-19	2011-11-29	Industrial Technology Research Institute	Glutathione-based delivery system
JP5333970B2 (ja) *	2007-03-20	2013-11-06	国立大学法人大阪大学	心筋梗塞の予防および／または治療薬
ES2322121B1 (es) *	2007-12-10	2010-04-19	Consejo Superior De Investigaciones Cientificas	Nuevos derivados de aminoacidos dicarboxilicos y su aplicacion en el tratamiento de enfermedades neurodegenerativas.
US8580742B2 (en)	2010-03-05	2013-11-12	N.V. Perricone Llc	Topical glutathione formulations for menopausal skin
US20110160144A1 (en) *	2009-12-28	2011-06-30	Perricone Nicholas V	Topical Acyl Glutathione Formulations
US8609604B2 (en)	2009-12-28	2013-12-17	N.V. Perricone Llc	Methods of improving the appearance of aging skin
WO2011156061A1 (en)	2010-06-07	2011-12-15	Telik, Inc.	Preparation of crystalline ezatiostat hydrochloride ansolvate form d
EP2576591A2 (de) *	2010-06-07	2013-04-10	Telik, Inc.	Tablettenformulierung aus ezatiostat
ES2708932T3 (es)	2011-06-21	2019-04-12	Nitto Denko Corp	Agente inductor de apoptosis
US20140120157A1 (en)	2012-09-19	2014-05-01	Georgetown University	Targeted liposomes
JP6340162B2 (ja)	2012-12-20	2018-06-06	日東電工株式会社	アポトーシス誘導剤
WO2015194522A1 (ja)	2014-06-17	2015-12-23	日東電工株式会社	アポトーシス誘導剤
US10264976B2 (en)	2014-12-26	2019-04-23	The University Of Akron	Biocompatible flavonoid compounds for organelle and cell imaging
RU2692065C1 (ru) *	2018-04-05	2019-06-20	федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ)	Глутатионаммониевые соли o,o-диорганилдитиофосфорных кислот, обладающие антиоксидантной и противоопухолевой активностью
JP7667077B2 (ja)	2018-11-16	2025-04-22	日東電工株式会社	Ｒｎａ干渉送達製剤及び悪性腫瘍のための方法
US11419849B1 (en)	2019-02-06	2022-08-23	Kitt Bio, Inc.	Methods and products for adverse effects of air travel, jet lag, or a change to a sleep wake timing cycle
JP7683931B2 (ja)	2019-05-14	2025-05-27	慶應義塾	抗腫瘍剤及び配合剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995005863A1 (en)	1993-08-27	1995-03-02	St. Paul Medical, Inc.	Needleless iv medical delivery system
DK0831877T3 (da) *	1995-06-07	2005-02-14	Telik Inc	Metabolske virkninger af visse glutathionanaloge
AU2226599A (en)	1998-01-21	1999-08-09	Telik, Inc.	Methods to identify myelostimulants
CN1185008C (zh)	1999-01-27	2005-01-19	泰立克公司	含有谷胱甘肽类似物的治疗用组合物

1999
- 1999-04-16 AT AT99914763T patent/ATE297945T1/de not_active IP Right Cessation
- 1999-04-16 JP JP2000544684A patent/JP4059627B2/ja not_active Expired - Fee Related
- 1999-04-16 CA CA002328731A patent/CA2328731A1/en not_active Abandoned
- 1999-04-16 EP EP99914763A patent/EP1072608B1/de not_active Expired - Lifetime
- 1999-04-16 WO PCT/JP1999/002044 patent/WO1999054346A1/ja not_active Ceased
- 1999-04-16 TW TW088106145A patent/TW576838B/zh active
- 1999-04-16 DE DE69925824T patent/DE69925824D1/de not_active Expired - Lifetime
- 1999-04-16 KR KR1020007011484A patent/KR20010042752A/ko not_active Ceased
- 1999-04-16 US US09/673,449 patent/US6627732B1/en not_active Expired - Fee Related
- 1999-04-16 AU AU33445/99A patent/AU766515B2/en not_active Ceased
2003
- 2003-07-21 US US10/622,799 patent/US20040018985A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP4059627B2 (ja)	2008-03-12
TW576838B (en)	2004-02-21
EP1072608A1 (de)	2001-01-31
EP1072608B1 (de)	2005-06-15
AU3344599A (en)	1999-11-08
US6627732B1 (en)	2003-09-30
AU766515B2 (en)	2003-10-16
CA2328731A1 (en)	1999-10-28
EP1072608A4 (de)	2001-09-19
WO1999054346A1 (en)	1999-10-28
US20040018985A1 (en)	2004-01-29
DE69925824D1 (de)	2005-07-21
KR20010042752A (ko)	2001-05-25

Legal Events

Date	Code	Title	Description
2005-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69925824D1 (de)	2005-07-21	Glutathionderivate und dazugehörige dosisformen
BR0109703A (pt)	2003-02-04	Derivados de piperazina
DK1041072T3 (da)	2003-11-10	Dioxocyclopentylhydroxamsyrer
NO2011026I2 (no)	2012-06-11	Eribulin eller et farmasøytisk akseptabelt salt derav
BR0016555A (pt)	2002-09-17	Composições farmacêuticas que proporcionam concentrações acrescidas de droga
MA26548A1 (fr)	2004-12-20	Compositions pharmaceutiques topiques contenant des derives de resorcinol.
ITRM990338A0 (it)	1999-05-28	Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
DE69604714D1 (de)	1999-11-25	Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
CY1108367T1 (el)	2014-02-12	Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
PT1129093E (pt)	2003-12-31	Derivados de pirazpolopirimidinona para o tratamento da impotencia
PT1235799E (pt)	2005-05-31	Forma polimorfica de atorvastatina-calcio
PT842934E (pt)	2004-03-31	Agonistas de 5-ht1f
PT911331E (pt)	2004-03-31	Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao
ATE224714T1 (de)	2002-10-15	Behandlung von tinnitus mit neuroprotektiven wirkstoffen
TR200003736T2 (tr)	2001-06-21	Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
NO20014925D0 (no)	2001-10-10	Farmasöytiske forbindelser
BR0300709A (pt)	2004-09-08	Sal de perindopril e as composições farmacêuticas contendo o mesmo
DE69913697D1 (de)	2004-01-29	Naphtho- und dihydrobenzothiophenderivate als cytotoxische antitumormittel
PA8531701A1 (es)	2003-06-30	Derivados de pirimidina
FR2792529B1 (fr)	2001-09-28	Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
EP1040832A4 (de)	2001-09-12	Vitamin d3 enthaltende cremen
TR199901782T2 (xx)	1999-09-21	Migren tedavisi i�in ibuprofen ve domperidon ihtiva eden farmas�tik bile�imler.
ID25478A (id)	2000-10-05	Agonis 5-ht1f
ATE274903T1 (de)	2004-09-15	Antivirale mittel
BR0108002A (pt)	2002-10-29	Derivados de amidas heterocìclicas